BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 1081550)

  • 21. Counterflow centrifugation allows addition of appropriate numbers of T cells to allogeneic marrow and blood stem cell grafts to prevent severe GVHD without substantial loss of mature and immature progenitor cells.
    Preijers FW; van Hennik PB; Schattenberg A; Ruijs P; Ploemacher RE; de Witte T
    Bone Marrow Transplant; 1999 May; 23(10):1061-70. PubMed ID: 10373074
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone marrow T cells. I. Response to the T cell mitogens, phytohemagglutinin and concanavalin A.
    Claman HN
    J Immunol; 1974 Mar; 112(3):960-4. PubMed ID: 4544179
    [No Abstract]   [Full Text] [Related]  

  • 23. Loss of proliferative capacity and T cell immune development potential by bone marrow from mice undergoing a graft-vs-host reaction.
    Iwasaki T; Fujiwara H; Iwasaki T; Shearer GM
    J Immunol; 1986 Nov; 137(10):3100-8. PubMed ID: 2945856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2----B10).
    Ildstad ST; Wren SM; Bluestone JA; Barbieri SA; Stephany D; Sachs DH
    J Immunol; 1986 Jan; 136(1):28-33. PubMed ID: 2933464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ontogeny of human T cells.
    Stites DP; Pavia CS
    Pediatrics; 1979 Nov; 64(5 Pt 2 Suppl):795-802. PubMed ID: 41216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Different subsets of T cells in the adult mouse bone marrow and spleen induce or suppress acute graft-versus-host disease.
    Palathumpat V; Dejbakhsh-Jones S; Holm B; Strober S
    J Immunol; 1992 Aug; 149(3):808-17. PubMed ID: 1386094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regeneration of T lymphocytes from human bone marrow cells after depletion with methylprednisolone.
    Yau JC; Chow HS; Kulkarni SS; Huynh LT; Zander AR
    J Clin Lab Immunol; 1986 Jan; 19(1):15-8. PubMed ID: 3517343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thymus dependency of antigen-binding cells in the bone marrow and spleen of chicks.
    Sato K
    Immunology; 1977 Feb; 32(2):171-7. PubMed ID: 300356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of levamisole on T lymphocyte colony formation by cells from bone marrow aspirates.
    Gordon MY
    Clin Exp Immunol; 1981 Aug; 45(2):365-70. PubMed ID: 6976244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cellular sorting methods in autologous (elimination of residual malignant cells) or allogeneic (T lymphocyte elimination) bone marrow grafts. Clinical pilot studies].
    Hervé P; Flesch M
    Nouv Rev Fr Hematol (1978); 1986; 28(2):97-105. PubMed ID: 2942838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms of corticosteroid action on lymphocyte subpopulations. I. Redistribution of circulating T and b lymphocytes to the bone marrow.
    Fauci AS
    Immunology; 1975 Apr; 28(4):669-80. PubMed ID: 1080130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Allogeneic bone marrow inhibits T-cell activation and clonal expansion in vitro.
    George JF; Lu A; Thomas JM; Kirklin JK; Pinderski LJ
    Transplantation; 2003 Jul; 76(1):237-43. PubMed ID: 12865816
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms responsible for defective human T-lymphocyte sheep erythrocyte rosette function associated with hepatitis B virus infections.
    Chisari FV; Routenberg JA; Edgington TS
    J Clin Invest; 1976 May; 57(5):1227-38. PubMed ID: 1083396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification by density separation of antigen-specific surface receptors on the progenitors of antibody-producing cells.
    Gorczynski RM; Miller RG; Phillips RA
    Immunology; 1971 May; 20(5):693-705. PubMed ID: 5317482
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A role for the thymic epithelium in the selection of pre-T cells from murine bone marrow.
    Bauvois B; Ezine S; Imhof B; Denoyelle M; Thiery JP
    J Immunol; 1989 Aug; 143(4):1077-86. PubMed ID: 2787355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human thymus-derived rosette-forming cells and immunologic diseases.
    Wybran J; Fudenberg HH
    Birth Defects Orig Artic Ser; 1975; 11(1):7-9. PubMed ID: 1096998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Canine lymphocyte subpopulations.
    Atkinson K; Deeg HJ; Storb R; Weiden PL; Gerhard-Miller L; Torok-Storb BJ; Seigneuret M; Thomas ED
    Exp Hematol; 1980 Aug; 8(7):821-9. PubMed ID: 16398012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of immunity in human severe primary T cell deficiency following haploidentical bone marrow stem cell transplantation.
    Buckley RH; Schiff SE; Sampson HA; Schiff RI; Markert ML; Knutsen AP; Hershfield MS; Huang AT; Mickey GH; Ward FE
    J Immunol; 1986 Apr; 136(7):2398-407. PubMed ID: 2869085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
    Li JM; Waller EK
    Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abnormal T-lymphocyte colonies (CFU-TL) following bone marrow transplantation.
    Mitsuyasu RT; Li SN; Champlin RE; Gale RP
    Exp Hematol; 1986 Dec; 14(11):1049-55. PubMed ID: 3536545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.